NICE and FDA to collaborate in medtech access scheme
December 15, 2016Medical Communications, Sales and Marketing FDA, NICE
The National Institute of Health and Care Excellence (NICE) and the US Food and Drugs Administration (FDA) have announced their …
Former CEO and president of generics company charged with price fixing
December 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeffrey glazer, heritage pharmaceuticals, jason malek
Jeffrey Glazer, ex-CEO of Heritage Pharmaceuticals, and Jason Malek, the former president, have been charged with conspiracy to fix prices. …
Five major pharma firms break ABPI code of conduct, according to watchdog
December 15, 2016Medical Communications, Sales and Marketing ABPI, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Grunenthal, Janssen
Eli Lilly, Boehgringer Ingelheim, AstraZeneca UK, Grunenthal and Janssen-Cilag have been “named and shamed” by the Prescription Medicines Code of …
Director and location of £250 million UK Dementia Research Institute revealed
December 14, 2016Medical Communications, Research and Development Alzheimer’s Research UK, Medical Research Council, alzheimer's research uk, alzheimer's society
Bart de Strooper has been chosen as the new director of the UK Dementia Research Institute (UK DRI), and University …
35% of all imported medicine in Guyana is fake, investigation finds
December 14, 2016Medical Communications, Research and Development, Sales and Marketing Guyana, counterfeit medicine
As much as 35% of medicine imported into Guyana is fake and unsafe for use, according to findings by Allan …
New York in $500 million de Blasio-backed biotech boost
December 14, 2016Manufacturing and Production, Research and Development New York, biotech, funding
Mayor of New York, Bill de Blasio, has announced a $500 million initiative to drive the development of the biotech …
Sanofi eyes Actelion merger as J&J backs down
December 14, 2016Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi
After days of negotiations, Johnson and Johnson has stepped down from its attempts to acquire Swiss blood-pressure specialist Actelion, while …
Obama seals $6.3 billion 21st Century Cures Act
December 14, 2016Medical Communications, Research and Development Biden, Obama, US, congress
President Barack Obama put pen to paper on the 21st Century Cures Act on 13 December, which commits to investing …
Lilly offers insulin at 40% discount
December 13, 2016Research and Development, Sales and Marketing Blink Health, Eli Lilly
Eli Lilly has announced that it will offer its insulin medication, including Humalog, at a 40% discount for eligible patients …
Specialist medical education company, Wave, has made six new appointments to reflect the growth in their business over the last 3 months.
December 13, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Becky Robbins, a former Healthcare Analyst at GlobalData, and Lorna Bosdet, formerly Account Executive at Sciterion have joined as Senior …
Alexion loses CEO & CFO as internal investigation continues
December 13, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion
Alexion Pharmaceuticals has revealed that its CEO David Hallal (pictured) and CFO Vikas Sinha have resigned effective immediately in connection …
Medicity in £1.4 million expansion in boost for life sciences
December 13, 2016Manufacturing and Production BioCity, Boots, medicity
Medicity has announced that it has managed to raise the funds to refurbish an additional 29,800 square feet of space, …
Major fire ravages Biocon subsidiary complex in India
December 13, 2016Manufacturing and Production Biocon, Syngene
A subsidiary of Indian biopharmaceutical firm Biocon was gutted by a major fire at Electronic City, Bangalore on 12 December, …
Sun Pharma’s Halol plant’s leaky roof irks FDA
December 13, 2016Manufacturing and Production FDA, Sun Pharma, inspection
The FDA’s two week inspection of Sun Pharmaceutical’s Halol plant produced a 14-page report, with some criticisms reserved for poorly …
Alexion loses CEO & CFO as internal investigation continues
December 12, 2016Business Services, Manufacturing and Production, Medical Communications
Alexion Pharmaceuticals has revealed that its CEO David Hallal and CFO Vikas Sinha have resigned effective immediately in connection with …
Scottish Medicines Consortium approves Sanofi’s prostate cancer drug
December 12, 2016Manufacturing and Production, Sales and Marketing Jevtana, Sanofi, prostate cancer
Sanofi’s speciality care global business unit Sanofi Genzyme has announced that the Scottish Medicines Consortium has accepted the company’s Jevtana …
Rare challenges: Meeting patient needs and delivering medical innovation in ultra-rare diseases
December 12, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, ultra rare disease, ultra-rare disease
Dr Emma Harvey, senior medical director at Alexion Pharmaceuticals UK, shares her views on the challenges of working in the …
Personalised leukaemia vaccine shows promise in new trial
December 12, 2016Sales and Marketing leukaemia
A personalised cancer vaccine has proven to have significant efficacy in the treatment of acute myeloid leukaemia (AML), researchers at …
Phase 3 eye drug combo failure for Novartis
December 12, 2016Research and Development, Sales and Marketing Novartis, ophthotech
Novartis’ has failed in its attempt to expand the applications of its anti-VEGF eye treatment Lucentis (ranibizumab) after the drug …
Neurodegenerative market to be worth $45 billion by 2022
December 12, 2016Sales and Marketing Biogen, GBI Research, Novartis, Roche, Sanofi, neurodegenerative
Neurodegenerative disorders including Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) form a lucrative worldwide market which …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
